Is hepatic peroxisome proliferator-activated receptor essential for the metabolic effects of fibrates?

被引：1
作者：
Kamijo, Y. [1 ,2 ]
机构：
[1] Shinshu Univ, Dept Nephrol, Sch Med, Nagano, Japan
[2] Shinshu Univ, Inst Pathogenesis & Dis Prevent, Dept Metab Regulat, Grad Sch Med, Nagano, Japan
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2018年 / 33卷 / 05期
关键词：
PPAR-ALPHA;
D O I：
10.1111/jgh.14126
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：978 / 979
页数：2
相关论文
共 15 条
  • [1] Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor α (PPARα)
    Aoyama, T
    Peters, JM
    Iritani, N
    Nakajima, T
    Furihata, K
    Hashimoto, T
    Gonzalez, FJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (10) : 5678 - 5684
  • [2] Possible Role of Intestinal Fatty Acid Oxidation in the Eating-Inhibitory Effect of the PPAR-α Agonist Wy-14643 in High-Fat Diet Fed Rats
    Azari, Elnaz Karimian
    Leitner, Claudia
    Jaggi, Thomas
    Langhans, Wolfgang
    Mansouri, Abdelhak
    [J]. PLOS ONE, 2013, 8 (09):
  • [3] Selective peroxisome proliferator-activated receptora modulators (SPPARMα): The next generation of peroxisome proliferator-activated receptor α-agonists
    Fruchart, Jean-Charles
    [J]. CARDIOVASCULAR DIABETOLOGY, 2013, 12
  • [4] Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-α
    Fu, J
    Gaetani, S
    Oveisi, F
    Lo Verme, J
    Serrano, A
    de Fonseca, FR
    Rosengarth, A
    Luecke, H
    Di Giacomo, B
    Tarzia, G
    Piomelli, D
    [J]. NATURE, 2003, 425 (6953) : 90 - 93
  • [5] The Fat-Induced Satiety Factor Oleoylethanolamide Suppresses Feeding through Central Release of Oxytocin
    Gaetani, Silvana
    Fu, Jin
    Cassano, Tommaso
    Dipasquale, Pasqua
    Romano, Adele
    Righetti, Laura
    Cianci, Silvia
    Laconca, Leonardo
    Giannini, Elisa
    Scaccianoce, Sergio
    Mairesse, Jerome
    Cuomo, Vincenzo
    Piomelli, Daniele
    [J]. JOURNAL OF NEUROSCIENCE, 2010, 30 (24) : 8096 - 8101
  • [6] Efficacy and safety of pemafibrate (K-877), a selective peroxisome proliferator-activated receptor α modulator, in patients with dyslipidemia: Results from a 24-week, randomized, double blind, active-controlled, phase 3 trial
    Ishibashi, Shun
    Arai, Hidenori
    Yokote, Koutaro
    Araki, Eiichi
    Suganami, Hideki
    Yamashita, Shizuya
    [J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2018, 12 (01) : 173 - 184
  • [7] Identification of functions of peroxisome proliferator-activated receptor α in proximal tubules
    Kamijo, Y
    Hora, K
    Tanaka, N
    Usuda, N
    Kiyosawa, K
    Nakajima, T
    Gonzalez, FJ
    Aoyama, T
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (07): : 1691 - 1702
  • [8] PPARα protects proximal tubular cells from acute fatty acid toxicity
    Kamijo, Yuji
    Hora, Kazuhiko
    Kono, Keiichi
    Takahashi, Kyoko
    Higuchi, Makoto
    Ehara, Takashi
    Kiyosawa, Kendo
    Shigematsu, Hidekazu
    Gonzalez, Frank J.
    Aoyama, Toshifumi
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (12): : 3089 - 3100
  • [9] Roles of PPARs in health and disease
    Kersten, S
    Desvergne, B
    Wahli, W
    [J]. NATURE, 2000, 405 (6785) : 421 - 424
  • [10] Plasma PCSK9 concentrations correlate with LDL and total cholesterol in diabetic patients and are decreased by fenofibrate treatment
    Lambert, Gilles
    Ancellin, Nicolas
    Charlton, Francesca
    Comas, Daniel
    Pilot, Julia
    Keech, Anthony
    Patel, Sanjay
    Sullivan, David R.
    Cohn, Jeffrey S.
    Rye, Kerry-Anne
    Barter, Philip J.
    [J]. CLINICAL CHEMISTRY, 2008, 54 (06) : 1038 - 1045
12